Summit Investment Advisors »

Cg Oncology shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $181k 4.8k 37.73
2024-06-30 $73k 2.3k 31.57
2024-03-31 $102k 2.3k 43.90

More positions owned by Summit Investment Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Etf (IVV)
Amazon (AMZN)
Vanguard Europe Pacific ETF (VEA)
Broadcom (AVGO)
Vanguard S&p 500 Etf idx (VOO)
iShares Lehman Aggregate Bond (AGG)
Spdr Ser Tr Etf (ONEV)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
iShares S&P 500 Growth Index (IVW)
Vanguard Total Bond Market ETF (BND)
iShares S&P 500 Value Index (IVE)

View all positions for Summit Investment Advisors

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
BlackRock
Braidwell
Vanguard Group
BlackRock
Avidity Partners Management
Henderson Group
RA Capital Management
Franklin Resources
Geode Capital Management
Alliancebernstein
BVF
State Street Corporation
Cormorant Asset Management

View all funds holding Cg Oncology